Researcher
An Coosemans
- Disciplines:Cancer therapy, Cancer biology, Neurosurgery
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Responsible
From1 Oct 2019 → Today - Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Sep 2016 → Today - Gynaecological Oncology (Division)
Member
From1 Oct 2013 → 31 Aug 2016 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 2012 → 30 Sep 2013
Projects
1 - 10 of 18
- Development of tumor-derived dendritic cell therapies to prevent ovarian cancer metastasisFrom13 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to deal with recurrent ovarian cancer: a new approach.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Developing combinatorial immunotherapy for glioblastomaFrom7 Nov 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Spectral flowcytometry (Cytek Aurora)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccinesFrom8 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Rational approach for immunotherapy in ovarian cancer.From1 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
Publications
21 - 30 of 110
- Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer(2021)
Authors: Christine De Bruyn, Jolien Ceusters, Thaïs Baert, Ann Vankerckhoven, Roxanne Wouters, Dominique Schols, Dirk Timmerman, Ignace Vergote, An Coosemans
- Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer(2021)
Authors: Jenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, Yani Berckmans, Roxanne Wouters, Thaïs Baert, Tom Bourne, Wouter Froyman, Dominique Schols, Patrizia Agostinis, et al.
- Immunological configuration of ovarian carcinoma: features and impact on disease outcome(2021)
Authors: An Coosemans, Ignace Vergote
- High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification(2021)
Authors: Siel Olbrecht, Pieter Busschaert, Jun Qian, Liselore Loverix, Toon Van Gorp, Els Van Nieuwenhuysen, Sileny Han, An Coosemans, Anne-Sophie Van Rompuy, Diether Lambrechts, et al.
- CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI(2021)
Authors: Liesbeth Vanherp, Matteo Riva, An Coosemans, Katrien Lagrou, Willy Gsell, Greetje Vande Velde, Uwe Himmelreich
- Type of chemotherapy has substantial effects on the immune system in ovarian cancer(2021)
Authors: Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Jolien Ceusters, Ignace Vergote, An Coosemans
- Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma(2021)
Authors: Matteo Riva, Roxanne Wouters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: E205 - E215 - Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma(2021)
Authors: Roxanne Wouters, Sien Bevers, Matteo Riva, Frederik De Smet, An Coosemans
- Noninvasive multimodal and multiparametric imaging for preclinical tumor characterization and nanoparticle validation(2020)
Authors: Sarah Belderbos, Uwe Himmelreich, An Coosemans
- Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors(2020)
Authors: Jolien Ceusters, Thaïs Baert, Wouter Froyman, Ruben Heremans, Anne-Sophie Van Rompuy, Dominique Schols, Ben Van Calster, Tom Bourne, Toon Van Gorp, Ignace Vergote, et al.
Pages: 811 - 819
Patents
1 - 4 of 4
Linked dataset
1 - 1 of 1